← Leaderboards
Stanimir Vuk-Pavlovic
Mayo Clinic Rochester
$509,383
Attributed
$509,383
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $183.9K · FY2008–10$200K$150K$100K$50K$0
'08
'09
'10
Funding mix
By agency
NIH$509,383 · 1
By mechanism
P50$509,383 · 1
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Isobel A Scarisbrick$6,619,062
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchClinical TrialsCell PreparationCellsClinical EffectivenessClinical EfficacyAntigensAcuteAttentionAntigen-Presenting CellsAftercareAutologous Dendritic CellsBaseCancer CellCancer PatientCancer TherapyCancer VaccinesAllogenicCd80 GeneCd8b1 GeneAutoantigensCell Differentiation ProcessAutologousClinical Trials Design
Grant awards (3)
A Randomized Phase II Clinical trial to Determine the Safety, Tolerability and Ef$183,870
P50 · FY2010 · CA · contact PI
A Randomized Phase II Clinical trial to Determine the Safety, Tolerability and Ef$183,870
P50 · FY2009 · CA · contact PI
A Randomized Phase II Clinical trial to Determine the Safety, Tolerability and Ef$141,643
P50 · FY2008 · CA · contact PI